Close

News

CSafe Global announces the opening of an expanded Service Center in Amsterdam increasing their operational footprint in Europe

CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, is pleased to announce the opening of a new service center in The Netherlands. This expanded facility will enable CSafe to further enhance...

Royal Cargo passes GDP re-certification audit for pharma logistics

Royal Cargo has announced that its Pharma/Clinical Trial Logistics and Premium Courier Service unit passed the Good Distribution Practices (GDP) re-certification audit. Pharma Logistics is a business unit of this Philippines-based company that provides Logistics Management Solutions for Pharmaceutical and...

Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into clinical trials

Cancer Research UK, the world’s leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled biotechnology company, have announced a partnership to develop Hummingbird’s anti-HER3 antibody drug, HMBD-001, for the treatment of people with HER3 driven cancer. Under the terms...

GSK grants exclusive technology license for clinical-stage Ebola vaccines to Sabin Vaccine Institute

GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed...

Pharmaceutical Grade Process Equipment Surplus to the needs of Teva Pharmaceuticals

Sale Highlights: Tank Farm & Distillation Syst. (35) Assorted Tanks-to 40,000 Liters Stainless, Plastic, Fiberglass & CS Assorted Pumps, Filters & Controls Stainless Pipework, Valves & Work Decks (2) Vapor Compression H2O Distillation Units, Manufactured by Cor Pharmaceuticals Factory Infrastructure: (2)...

Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS)

Sarepta Therapeutics, Inc, the leader in precision genetic medicine for rare diseases, was informed earlier  that an adverse event report was erroneously submitted to the FDA’s adverse event reporting system (FAERs), a post-marketing surveillance database for approved therapies. Our...

Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform

Vesselon, an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent®. Vesselon will use Imagent to create novel therapeutic complexes in four classes of cancer drugs: cytokines, oncolytic viruses, monoclonal antibodies, and nucleic acid constructs. Vesselon incorporates Imagent...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »